Biotechnology Global News & Press Release Distribution

Biotechnology

All
APAC

Clene Nanomedicine, Inc. to go Public through Merger with Tottenham Acquisition I Limited

* Clene is a clinical-stage biopharmaceutical company developing the first potential therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neur...

2020-09-02 20:00 18863

bitBiome has raised 700 million JPY in Seed financing

TOKYO, Sept. 1, 2020 /PRNewswire/ -- bitBiome, Inc., an emerging leader in microbiome analytics, has raised700 million JPY (approx. $6.6m US) in seed financing from previous and new investors including TheUniversity of Tokyo Edge Capital Partners, Universal Materials Incubator, and otherJapan-ba...

2020-09-02 11:28 1940

Origin Agritech to Present at The LD 500 Virtual Conference

BEIJING,, Aug. 31, 2020 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, today announced that it will be presenting at the LD 500 investor conference on Friday, September 4th at8 AM PST / 11 AM EST. Origin's Chairman and Chief Ex...

2020-09-01 01:41 16939

Transcenta Announces First Patient Dosed in Phase I China Trial of Claudin18.2 Targeting Monoclonal Antibody TST001

SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successful...

2020-08-31 23:00 2043

Shandong stages welcoming event for Europe's Fortune 500 companies

JINAN, China, Aug. 30, 2020 /PRNewswire/ -- The "Connecting Shandong with Fortune Global 500" series of events, hosted by the CPC Shandong Provincial Committee and Shandong Provincial People's Government, organized by the Department of Commerce ofShandong Province, and sponsored by FORTUNE CHINA,...

2020-08-31 10:42 2523

Shandong stages welcoming event for Europe's Fortune 500 companies

New finding - Patient Blood Management delivers cost-effective care

BASEL, Switzerland, Aug. 28, 2020 /PRNewswire/ -- Research recently published in the journal Anaesthesia , looked at the economic case for screening and treating anaemia and iron deficiency prior to elective surgery. The five-year stud...

2020-08-28 16:31 1390

GoBroad Healthcare Group Showcases Innovative Hematologic Treatment Capabilities at the China Precision Medicine Forum

BEIJING, Aug. 26, 2020 /PRNewswire/ -- GoBroad Healthcare Group hosted the China Precision Medicine Forum in Hematologic Malignancies & 2nd GoBroad Annual Medical Conference (diagnosis and treatment of diseases of the blood and bone marrow) in early August, covering subjects including diagnosis, ...

2020-08-26 21:00 2158

GoBroad Healthcare Group Showcases Innovative Hematologic Treatment Capabilities at the China Precision Medicine Forum

RoboPharma Acquired by Capsa Healthcare to Broaden Reach Into New Pharmacy Automation Markets

WAALWIJK, Netherlands, Aug. 26, 2020 /PRNewswire/ -- RoboPharma announced today the company has been acquired by Capsa Healthcare, a worldwide innovator in healthcare delivery solutions for hospitals, senior care settings, and retail pharmacy providers. Becoming an integral segment within Capsa H...

2020-08-26 08:12 2509

CARsgen Therapeutics Receives IND Clearance from the NMPA for CT041 CLDN18.2-CAR-T Cells

SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- CARsgen Therapeutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that the National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application for the first-in-class drug candidate CT041, auto...

2020-08-20 18:32 4448

PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS

DAEJEON, South Korea, Aug. 18, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a Materials Cooperative Research and Development Agreement (MCRADA) with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), in whic...

2020-08-18 21:00 8679

Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results

HONG KONG, Aug. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...

2020-08-18 19:00 3932

China Biologic Reports Financial Results for the Second Quarter of 2020

BEIJING, Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the second quarter of 2020. Second Quart...

2020-08-18 04:30 9974

I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China

SHANGHAI and GAITHERSBERG, Md., Aug. 17, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed with plonmarlimab ...

2020-08-17 20:00 3606

WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations

WuXi AppTec Second-Quarter 2020 Results Revenue Up 29.4% YoY to RMB4,044 Million Net Profit Attributable to Owners of the Company Up 111.0% YoY to RMB1,414 Million Diluted EPS Up 110.3% YoY to RMB0.61 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 43.1% YoY toRMB942 Million...

2020-08-13 16:49 5164

Fapon 2nd COVID-19 Donation, 100 Million Anti-SARS-CoV-2 Fully Human RBD IgM & IgG QC Test Materials

DONGGUAN, China, Aug. 10, 2020 /PRNewswire/ -- Fapon Biotech Inc . (Fapon), a global leading IVD raw materials and one-stop solutions company, announces a new COVID-19 donation to meet the urgent demand for development and optimization of reliable quality controls for high-...

2020-08-10 20:00 1932

Fapon 2nd COVID-19 Donation, 100 Million Anti-SARS-CoV-2 Fully Human RBD IgM & IgG QC Test Materials

China Biologic Products to Report Second Quarter 2020 Financial Results

BEIJING, Aug. 10, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its second quarter 2020 financial results ...

2020-08-10 20:00 8919

VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update

AUSTIN, Texas, Aug. 10, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onFriday, August 14, at 8:30 a.m. Eastern time to discuss its financial and operating results for the second quarter 2020, in addition to providing a b...

2020-08-10 19:30 7904

Co-Diagnostics, Inc. Logix Smart™ COVID-19 Test Authorized for Use in Australia

SALT LAKE CITY, Aug. 7, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today thatAustralia has been added to the list of countries that have authorized the Logix Smart™ C...

2020-08-07 18:30 9145

ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies

SHENZHEN and SHANGHAI, August 6, 2020 /PRNewswire/ -- ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd today announced a clinical collaboration and exclusive license agreement for ImmVira's MVR-T3011 intratumoral oncolytic virus program for the commercialization of novel immun...

2020-08-06 23:49 9597

ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies

I-Mab to Report Financial Results for the Six Months Ended June 30, 2020 and Provide Corporate Update on August 31, 2020

SHANGHAI and GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it will report financial results for the six months ...

2020-08-06 20:30 14870

1 ... 122 123 124125126 127 128 ... 132